Antigenic Peptide Of Hsv-2 And Methods For Using Same


The invention provides HSV antigens that are useful for the prevention and treatment of HSV infection, including epitopes confirmed to be recognized by T-cells derived from herpetic lesions. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.

Download PDF
Document Preview
Document History
  • Publication: Feb 28, 2017
  • Application: Jun 1, 2015
    US US 201514727666 A
  • Priority: Jun 1, 2015
    US US 201514727666 A
  • Priority: Oct 3, 2011
    US US 201113262833 A
  • Priority: Apr 3, 2010
    US US 2010/0029880 W
  • Priority: Jul 24, 2009
    US US 22848909 P
  • Priority: Apr 3, 2009
    US US 16663709 P

Download Citation

Sign in to the Lens